Fengzhen Mo

The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide

Chunhui Lai, Siliang Duan, Fang Ye et al. · Theranostics · 2018 · 104 citations · Full text

Medicine, Immunology, Oncology +17

Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy

Fengzhen Mo, Siliang Duan, Xiaobing Jiang et al. · Signal Transduction and Targeted Therapy · 2021 · 81 citations · Full text

Life Sciences, Biotechnology, Oncology +17

Fusion of Dendritic Cells and Cancer-Associated Fibroblasts for Activation of Anti-Tumor Cytotoxic T Lymphocytes

Liwen Qian, Zhuoran Tang, Shihua Yin et al. · Journal of Biomedical Nanotechnology · 2018 · 45 citations

Life Sciences, Immunology, Oncology +17

<p>In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice</p>

Ziqiang Ding, Dujin Wang, Wei Shi et al. · International Journal of Nanomedicine · 2020 · 42 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine

Wei Shi, Xiaomei Yang, Shenxia Xie et al. · Cancer Letters · 2021 · 39 citations

Life Sciences, Immunology, Oncology +16